Company / EPS (Diluted)
Fulgent Genetics, Inc. EPS (Diluted) History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.01
FY2017
5-year range
-
FY2016-FY2017
Trend
+150.0%
vs FY2016
Sector context
#94 of 159
Health Care
What the data says
At $0.01, Fulgent Genetics, Inc.'s eps (diluted) ranks #94 of 159 in the Health Care sector.
Based on SEC 10-K filings.
0.01 in FY2017.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 159 in Health CareTop 59% of 159This company $0.01 Sector average $1.67
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2017, eps (diluted) increased 150.0% year-over-year.
- Ranks #94 out of 159 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.01 | +150.0% |
| FY2016 | -$0.02 | - |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026